hackint0sh/New-Dataset huggingface dataset:
nctId: NCT06311487 id: 23-1388 id: 1R56DK136601-01 type: NIH link: https://reporter.nih.gov/quickSearch/1R56DK136601-01 briefTitle: Time and Nutrient-Dependent Effects of Aerobic Exercise on Metabolism in Adults (TANDEM Study) acronym: TANDEM overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2025-08 date: 2025-08 date: 2024-03-15 date: 2024-03-29 name: University of Colorado, Denver class: OTHER name: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) briefSummary: This study plans to learn more about metabolic responses to aerobic exercise at different times of the day (morning or evening) under fasting versus fed conditions. conditions: Overweight and Obesity conditions: Healthy studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: OTHER masking: NONE count: 20 type: ESTIMATED name: Fasted-AM name: Fed-AM name: Fasted-PM name: Fed-PM measure: Exercise Energy Expenditure (kcals) measure: Substrate Oxidation (Respiratory Quotient) sex: ALL minimumAge: 18 Years maximumAge: 40 Years stdAges: ADULT facility: University of Colorado Anschutz Medical Campus city: Aurora state: Colorado zip: 80045 country: United States name: Justin Lorentzen, BHS role: CONTACT phone: 303-724-3685 email: justin.lorentzen@cuanschutz.edu name: Shelby Panter, MS role: CONTACT phone: 303-724-3202 email: shelby.panter@cuanschutz.edu name: Seth Creasy, PhD role: PRINCIPAL_INVESTIGATOR lat: 39.72943 lon: -104.83192 hasResults: False
nctId: NCT06311461 id: 22-001111 briefTitle: Effects of Acupuncture on Symptoms of Stable Angina acronym: EASE overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2026-12-31 date: 2027-06-30 date: 2024-03-15 date: 2024-03-15 name: University of California, Los Angeles class: OTHER name: University of Illinois at Chicago briefSummary: The goal of this clinical trial is to determine if a standardized 12-point acupuncture protocol will reduce pain in participants with stable angina.
The investigators will test the efficacy of acupuncture for stable angina/chest pain syndrome to reduce pain and symptoms, improve health-related quality of life, reduce healthcare utilization and and improve patient related health outcomes. conditions: Angina, Stable studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: DOUBLE whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 112 type: ESTIMATED name: Acupuncture name: Attention control measure: Pain Now measure: Worst Pain measure: Least Pain measure: Acute Coronary Syndrome like symptoms (ACS Symptom Checklist) measure: Anginal Pain (Seattle Angina Questionnaire-7) measure: Number of Angina Attacks (From American Heart Association Angina Log) measure: Symptom Triggers (From American Heart Association Angina Log) measure: Pain from Angina Attack (From American Heart Association Angina Log) measure: Length of Angina Attack (American Heart Association Angina Log) measure: Self-treatment for Symptoms (From American Heart Association Angina Log) measure: Functional Status Related to Angina (Seattle Angina Questionnaire-7) measure: General Functional Status (PROMIS 29v.2) measure: Quality of Life (Seattle Angina Questionnaire-7) measure: Use of Nitrates and Analgesics (AHA Angina log) measure: Patient Reported Outcomes (Patient Reported Outcomes Measurement Information System-29v.2 measure: Healthcare Utilization measure: Ischemia on Electrocardiogram (ECG) sex: ALL minimumAge: 21 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06311448 id: 10094 briefTitle: Personalized Targeted Immunomodulation in COVID-19 ARDS acronym: COMODULATE overallStatus: COMPLETED date: 2020-03-02 date: 2022-02-01 date: 2022-02-01 date: 2024-03-15 date: 2024-03-15 name: Erasmus Medical Center class: OTHER name: Amsterdam UMC name: Leiden University Medical Center name: St. Antonius Hospital briefSummary: Rationale: In COVID19 single-targeted immunomodulation, mostly via an IL-6 receptor blocker, was used by a one-size fits all non-targeted approach. In future pandemics the same might occur. However, for individual patients, this might not yield optimal treatment.
Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Given the retrospective nature of the study, no burden, risks or benefits for the patient are associated with participation. The target population of this study is specific to hospitalized patients with COVID-19. conditions: COVID-19 Acute Respiratory Distress Syndrome studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: RETROSPECTIVE count: 164 type: ACTUAL name: Single target immunomodulation name: Standard of care measure: Mortality up to day 90 measure: Change in SOFA score measure: Ventilator free days measure: Change in biomarker values measure: Costs of immmunomodulation sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Erasmus Medical Centre city: Rotterdam state: Zuid-Holland zip: 3015 GD country: Netherlands lat: 51.9225 lon: 4.47917 hasResults: False
nctId: NCT06311435 id: FBB-RNA-004 briefTitle: Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19 overallStatus: RECRUITING date: 2024-03-15 date: 2026-03-15 date: 2026-03-15 date: 2024-03-15 date: 2024-03-15 name: MaxWell Clinic, PLC class: INDUSTRY briefSummary: The primary objective of this study is to determine, in unblinded samples, whether artificial intelligence can classify specific blood RNA from patients with long COVID together and separately from apparently healthy normals and other medical conditions which share signs and symptoms of long COVID. conditions: Long COVID studyType: INTERVENTIONAL phases: NA allocation: NON_RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Participants will be placed into one of eleven possible cohorts based on their presenting complaints. primaryPurpose: DIAGNOSTIC masking: SINGLE maskingDescription: Patients will be assigned a random number from the electronic health record. The only information shared with the sponsor will be Pt ID number, age, gender and state of residence. whoMasked: PARTICIPANT count: 3000 type: ESTIMATED name: RNA Biomarker Blood Test measure: Artificial Intelligence Identified number of RNA Biomarkers for Long COVID measure: Artificial Intelligence Identified number of RNA Biomarkers for specific Long COVID subgroups sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: The MaxWell Clinic status: RECRUITING city: Brentwood state: Tennessee zip: 37027 country: United States name: Justin Davis role: CONTACT phone: 615-370-0091 email: Justin@maxwellclinic.com name: Cale T Queen, PhD role: CONTACT phone: 16153700091 email: cale@maxwellclinic.com name: David H Haase, MD role: PRINCIPAL_INVESTIGATOR lat: 36.03312 lon: -86.78278 facility: The MaxWell Clinic status: RECRUITING city: Brentwood state: Tennessee zip: 37027 country: United States name: Justin Davis role: CONTACT phone: 615-370-0091 email: justin@maxwellclinic.com name: Cale T Queen, PhD. role: CONTACT phone: 6153700091 email: cale@maxwellclinic.com name: David H Haase, MD role: PRINCIPAL_INVESTIGATOR lat: 36.03312 lon: -86.78278 hasResults: False
nctId: NCT06311422 id: CAD/CAM-endocrown briefTitle: A 3-Year Clinical Evaluation Of Endocrown Restorations With Two Different Materials overallStatus: ACTIVE_NOT_RECRUITING date: 2020-03-15 date: 2023-03-15 date: 2028-09-15 date: 2024-03-15 date: 2024-03-19 name: Hacettepe University class: OTHER briefSummary: The clinical performance of two different materials in endodontically treated teeth produced with CAD/CAM system will be evaluated and compared. After obtaining a signed informed consert form from all the patients, all restorations will be placed by a single clinician. All endocrown restorations will be produced using the same CAD/CAM system. 52 restorations will be fabricated using Lava Ultimate (LU, 3M Espe, Seefeld, Germany) blocks and 38 restorations will be fabricated using Celtra Duo (CD, Dentsply Sirona, York, PA, USA) blocks. All restorative procedures will be conducted according to manufacturers' instructions. Restorations will be scored using modified United States Public Health Service (USPHS) criteria after baseline, 6,12,36, 48, 60 months. Descriptive statistics will be performed using Chi-square and Fisher exact test. conditions: Endodontically Treated Teeth studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: DOUBLE whoMasked: PARTICIPANT whoMasked: INVESTIGATOR count: 74 type: ACTUAL name: resin nanoceramic block name: zirconia-reinforced lithium silicate measure: Clinical performance of two materials sex: ALL minimumAge: 18 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Hacettepe University Faculty of Dentistry city: Ankara zip: 06060 country: Turkey lat: 39.91987 lon: 32.85427 hasResults: False
nctId: NCT06311409 id: SMFS2019 briefTitle: Validation Study of the Speedy Meyer Fall Scale for Determining the Fall Risk of the Paediatric Patient overallStatus: RECRUITING date: 2020-01-29 date: 2024-03 date: 2024-04 date: 2024-03-15 date: 2024-03-15 name: Meyer Children's Hospital IRCCS class: OTHER briefSummary: Fall prevention is an essential element in ensuring safe care for paediatric patients. The first step in building a risk reduction programme is the adoption of an assessment tool to identify those most at risk at an early stage. From October 2014 to date, a study has been conducted for the linguistic-cultural validation of the Humpty Dumpty Fall Scale (HDFS) in the Italian context, through a multicentre survey with the help of the Clinical Risk Management Group of the Region of Tuscany.
The objective of this study is the validation of the new Humpty Dumpty Fall Scale defined as Speedy Meyer-Fall Scale (SMFS) by assessing the comprehension and validity of the scale and items via Content Validity Index (SCVI and ICVI) estimation of inter-item reliability (Crombach's alpha), inter-rater reliability (Cohen's K), sensitivity, specificity, PPV, NPV and ROC curve. conditions: Fall Prevention studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 332 type: ESTIMATED measure: validation of the SMFS t measure: identification of patients high risk of falls sex: ALL minimumAge: 1 Year maximumAge: 16 Years stdAges: CHILD facility: AUSL Toscana Sud Est status: NOT_YET_RECRUITING city: Arezzo zip: 51100 country: Italy lat: 43.46276 lon: 11.88068 facility: Meyer Children's Hospital IRCCS status: RECRUITING city: Florence country: Italy name: Daniele Ciofi role: CONTACT email: daniele.ciofi@meyer.it lat: 43.77925 lon: 11.24626 facility: Fondazione Gabriele monasterio - Ospedale Pediatrico Apuano Massa status: NOT_YET_RECRUITING city: Massa country: Italy lat: 44.03541 lon: 10.13927 hasResults: False
nctId: NCT06311396 id: REVEAL briefTitle: Development of a Neuronal Microscope overallStatus: RECRUITING date: 2021-01-01 date: 2024-01-01 date: 2025-01-01 date: 2024-03-15 date: 2024-03-15 name: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico class: OTHER briefSummary: Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and is a leading cause of cancer-related death worldwide. The prognosis of HCC remains poor, with a 5-year survival rate of 18%. Risk factors for HCC include viral infection, autoimmune hepatitis, chronic alcohol use or metabolic fatty liver disease, obesity, and diabetes mellitus. conditions: Hepatic Carcinoma studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: PREVENTION masking: NONE count: 30 type: ESTIMATED name: genetic model measure: Isolation of epithelial cells measure: Omics studies and functional morphological studies sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Istituto di Ricovero e Cura a Carattere Scientifico di natura pubblica status: RECRUITING city: Milan state: Milano zip: 20122 country: Italy name: Luca Vittorio Carlo Valenti role: CONTACT phone: 02 5503 6595 phoneExt: 56595 email: luca.valenti@policlinico.mi.it lat: 45.46427 lon: 9.18951 typeAbbrev: Prot_SAP hasProtocol: True hasSap: True hasIcf: False label: Study Protocol and Statistical Analysis Plan date: 2020-12-09 uploadDate: 2024-03-08T10:03 filename: Prot_SAP_000.pdf size: 2182994 hasResults: False
nctId: NCT06311370 id: 2023-0100 briefTitle: Acceptability, Feasibility, and Development of an AI Driven, Multi-sensor, Non-invasive Digital Mental Health Platform in Children With ADHD and Emotional Symptoms overallStatus: COMPLETED date: 2023-08-09 date: 2024-02-05 date: 2024-02-05 date: 2024-03-15 date: 2024-03-15 name: MaxisHealth class: INDUSTRY briefSummary: This is an observational study collecting data using a wearable to measure the biometric features in youth with Attention deficit hyperactivity disorder(ADHD) and Autism. conditions: ADHD conditions: Autism studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 10 type: ACTUAL name: Observation measure: Emotion dysregulation sex: ALL minimumAge: 4 Years maximumAge: 7 Years stdAges: CHILD facility: The League School city: Brooklyn state: New York zip: 11203 country: United States lat: 40.6501 lon: -73.94958 hasResults: False
nctId: NCT06311357 id: 100/2566 briefTitle: Percent Weight Change in the Medical Supplement Group of Early Breast Cancer overallStatus: RECRUITING date: 2023-07-12 date: 2024-04-26 date: 2024-04-30 date: 2024-03-15 date: 2024-03-15 name: Rajavithi Hospital class: OTHER_GOV briefSummary: The goal of this RCT is to compare percent weight change in early breast cancer who takes medical supplement or not, during treatment with chemotherapy (standard AC regimen).
* control group - Nutritional advise during chemotherapy treatment. conditions: Early Stage Breast Cancer studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: SUPPORTIVE_CARE masking: SINGLE whoMasked: INVESTIGATOR count: 40 type: ESTIMATED name: Ensure measure: Percent weight change measure: EORTC QLQ-C30 measure: Patient interpretation of the Patient-Generated Subjective Global Assessment measure: EORTC QLQ-BR23 sex: FEMALE minimumAge: 18 Years maximumAge: 80 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Rajavithi hospital status: RECRUITING city: Ratchathewi state: Bangkok zip: 10400 country: Thailand name: Meitinarth Juntong role: CONTACT phone: +66654415447 email: juntong.mei@gmail.com lat: 13.759 lon: 100.53358 hasResults: False
nctId: NCT06311344 id: 2021-06 briefTitle: Filling Key Research Gaps With Clinical Implications in Mansonellosis and Schistosomiasis: a Network Approach overallStatus: RECRUITING date: 2021-04-14 date: 2024-03-31 date: 2024-03-31 date: 2024-03-15 date: 2024-03-15 name: IRCCS Sacro Cuore Don Calabria di Negrar class: OTHER briefSummary: This is an experimental, multicenter, non-profit study promoted by the Department of Infectious and Tropical Diseases of the IRCCS (Istituto di Ricerca e Cura a carattere scientifico) Sacro Cuore Don Calabria of Negrar which aims to evaluate the presence of endosymbiont Wolbachia in circulating microfilariae obtained from biological samples of individuals infected with M .perstans and the presence of infection with hybrid Schistosoma species in the population of Schistosoma eggs isolated from biological samples of patients with active schistosomiasis. conditions: Schistosoma Mansoni studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: BASIC_SCIENCE masking: NONE count: 200 type: ESTIMATED name: Molecular biology analyses measure: Number of M. perstans microfilariae measure: Percentage of M. perstans microfilariae measure: Number of Schistosoma eggs measure: Percentage of Schistosoma eggs measure: Number of samples positive for Wolbachia measure: Percentage of samples positive for Wolbachia measure: Number of samples positive for Schistosoma hybrid species measure: Percentage of samples positive for Schistosoma hybrid species measure: Identification of hybrid species of Schistosoma spp. sex: ALL stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: IRCCS Sacro Cuore Don Calabria hospital status: RECRUITING city: Negrar state: Verona zip: 37024 country: Italy name: Elena Pomari role: CONTACT phone: +390456013111 email: elena.pomari@sacrocuore.it name: Elena Pomari role: PRINCIPAL_INVESTIGATOR name: Francesca Tamarozzi role: SUB_INVESTIGATOR name: Bonnie Webster role: SUB_INVESTIGATOR lat: 45.52918 lon: 10.93899 hasResults: False
nctId: NCT06311331 id: restor3d-007 briefTitle: Prospective Evaluation of Clinical and Radiographic Outcomes Following Total Talus Replacement (PROCLAIM) overallStatus: NOT_YET_RECRUITING date: 2024-05 date: 2031-05 date: 2031-05 date: 2024-03-15 date: 2024-03-15 name: Restor3D class: INDUSTRY briefSummary: This is a Humanitarian Device Exemption (HDE) approved device. The purpose of this study is to evaluate the continued safety and probable benefit of the restor3d Total Talus Replacement device in commercial use. conditions: Avascular Necrosis of the Talus conditions: Talar Osteochondral Defect of Ankle conditions: Talar Dysfunction studyType: OBSERVATIONAL observationalModel: CASE_ONLY timePerspective: PROSPECTIVE count: 50 type: ESTIMATED name: Total Talus Replacement (TTR) measure: Proportion of participants who pass a composite of safety and probable benefit outcomes measure: Change in perceived pain from baseline measure: Change in Foot and Ankle Outcome Score (FAOS) Composite score from baseline measure: Change in Foot and Ankle Outcome Score (FAOS) pain subscale score from baseline measure: Change in Foot and Ankle Outcome Score (FAOS) other symptoms subscale score from baseline measure: Change in Foot and Ankle Outcome Score (FAOS) activities of daily living (ADL) subscale score from baseline measure: Change in Foot and Ankle Outcome Score (FAOS) sports/recreation subscale score from baseline measure: Change in Foot and Ankle Outcome Score (FAOS) quality of life (QOL) subscale score from baseline measure: Change in ankle range of motion (ROM) from baseline measure: Proportion of procedure-related Serious Adverse Events measure: Proportion of Adverse Events sex: ALL minimumAge: 22 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06311318 id: Department of surgery MED CMU briefTitle: Post-operative Lower Eyelid Massage for Prevention of the Lower Eyelid Scare Contracture After Subciliary Approach acronym: RCT overallStatus: COMPLETED date: 2016-11-01 date: 2019-11-30 date: 2020-09-30 date: 2024-03-15 date: 2024-03-15 name: Chiang Mai University class: OTHER briefSummary: Patients were randomly allocated to the lower eyelid massage (experimental) or standard care (control) groups. The massage group received post-operative instructions. Data on demographics, injury profiles, lower eyelid scar contracture (graded by GLESCO criteria), eyelid malpositioning, comfort scores, and complications were gathered over a 6-month follow-up. conditions: Zygomatic and Lefort II Fractures conditions: Infraorbital Rim Fixation conditions: Subciliary Approach Repair studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: A randomized controlled trial enrolled patients with traumatic facial fractures slated for subciliary approach repair. Patients were randomly allocated to the lower eyelid massage (experimental) or standard care (control) groups. The massage group received post-operative instructions. Data on demographics, injury profiles, lower eyelid scar contracture (graded by GLESCO criteria), eyelid malpositioning, comfort scores, and complications were gathered over a 6-month follow-up. primaryPurpose: PREVENTION masking: SINGLE maskingDescription: Patients were randomly assigned, using concealed block of four randomization, to either the experimental group receiving lower eyelid massage or the control group receiving standard care. While the authors, acting as massage trainers, were unblinded, an independent plastic surgeon, serving as the assessor, remained blinded to the study interventions. whoMasked: OUTCOMES_ASSESSOR count: 59 type: ACTUAL name: lower eyelid massage measure: Grading of Lower Eyelid Scar Contracture (GLESCO) measure: Grading of lower eyelid malpositioning measure: Comfort scores sex: ALL stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06311305 id: Soh-med-24-03-07MS briefTitle: Does Early Laparoscopic Cholecystectomy After ERCP Reduce the Risk of Complications overallStatus: RECRUITING date: 2024-03-01 date: 2024-08-01 date: 2024-08-20 date: 2024-03-15 date: 2024-03-15 name: Sohag University class: OTHER briefSummary: Gallstones have been recognised since antiquity and have been found during autopsies of Egyptian mummies. Following the first successful open cholecystectomy in 1882, it was Eric Muhe, a German surgeon, who performed the first laparoscopic cholecystectomy (Lapara, the flank; and skopein, to examine) in 1985.
Incidence of CBD stones in cases of cholelithiasis is around 3.4%-15%.2 Choledocholithiasis can either be primary or secondary. Secondary Choledocholithiasis being more common occurs due to stones originating in gallbladder and then migrating through cystic duct to CBD. Primary bile duct stones originate from within bile ducts and are more common in Asian populations. These stones are associated with biliary stasis and bacteria. conditions: Cholelithiases studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP interventionModelDescription: we aim to assess if the early laparoscopic cholecystectomy after ERCP can reduce the risks or complications primaryPurpose: TREATMENT masking: NONE maskingDescription: NONE (open label single group) count: 30 type: ESTIMATED name: Early Laparoscopic cholecystectomy measure: bile leakage measure: operative time measure: intraoperative bleeding measure: sepsis sex: ALL minimumAge: 15 Years maximumAge: 70 Years stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: Sohag University status: RECRUITING city: Sohag zip: 82511 country: Egypt name: Abdulla M Ahmed, master role: CONTACT phone: 01006546957 phoneExt: 002 email: abdallah_mohamed_ex@med.sohag.edu.eg name: Abdulla M Ahmed, master role: PRINCIPAL_INVESTIGATOR lat: 26.55695 lon: 31.69478 hasResults: False
nctId: NCT06311292 id: STUDY22090138 briefTitle: Intrapulmonary Percussive Ventilation for Sputum Induction in Adults With Cystic Fibrosis overallStatus: RECRUITING date: 2024-04 date: 2024-12 date: 2025-06 date: 2024-03-15 date: 2024-04-15 name: Daniel J. Weiner class: OTHER briefSummary: This is a small pilot study with the goal of identifying a superior sputum collection method in Cystic Fibrosis patients unable to produce a sputum.
Participants will use the Volara System during clinic visit in an attempt to produce sputum. conditions: Cystic Fibrosis studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: OTHER masking: NONE maskingDescription: No parties will be prevented from having knowledge of the Volara System use. count: 20 type: ESTIMATED name: Volara System measure: Sufficient sputum quantity for a pellet sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: UPMC Presbyterian Hospital status: RECRUITING city: Pittsburgh state: Pennsylvania zip: 15213 country: United States name: Elizabeth Hartigan, MPH, RN role: CONTACT phone: 412-692-7060 email: elizabeth.hartigan@chp.edu name: Jamie Adams, BS, RRT role: CONTACT email: adamsjm2@upmc.edu name: Daniel Weiner, MD role: PRINCIPAL_INVESTIGATOR lat: 40.44062 lon: -79.99589 hasResults: False